Product Description

CLAV 1.2 Injection is an injectable formulation containing Amoxycillin and Potassium Clavulanate with a total strength of 1.2 g. Amoxycillin is a penicillin-class antibacterial agent, while clavulanate helps inhibit certain beta-lactamases that can otherwise reduce the activity of amoxycillin.

The product is labelled for I.V. use only and is intended for administration by a qualified healthcare professional when intravenous antibacterial therapy is clinically indicated.

Therapeutic Information

CLAV 1.2 combines a beta-lactam antibacterial (amoxycillin) with a beta-lactamase inhibitor (clavulanate).

It may be used under medical supervision for susceptible bacterial infections where this combination and the intravenous route are appropriate.

Potential clinical applications can include certain:

• Respiratory tract infections
• Urinary tract infections
• Skin and soft-tissue infections
• Intra-abdominal infections
• Other susceptible bacterial infections

IMPORTANT : The actual indication, dose, frequency and treatment duration must be determined by the prescribing healthcare professional based on the infection, patient factors and local antimicrobial guidance.